SMLR - NASDAQ
Semler Scientific, Inc.
$20.33
+0.0000%Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
At a Glance
Live Snapshotsmlr
Additional Paid-In Capital
Last Annual Value
130.04M
3-Year CAGR
85%
5-Year CAGR
46%
10-Year CAGR
22%
Semler Scientific, Inc. Competitors Analysis of Additional Paid-In Capital
| Company | Additional Paid-In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Semler Scientific, Inc. NASDAQ:SMLR | 130.04M | 121.4% | 44.5% | 19.4% | |
 Senseonics Holdings, Inc. NASDAQ:SENS | 1.08B | 6.0% | 7.1% | 18.4% | |
 RxSight, Inc. NASDAQ:RXST | 0.00 | N/A | N/A | N/A | |
 Delcath Systems, Inc. NASDAQ:DCTH | 639.14M | 7.1% | 8.1% | 8.7% | |
 Perspective Therapeutics, Inc. AMEX:CATX | 0.00 | N/A | N/A | N/A | |
 Tactile Systems Technology, Inc. NASDAQ:TCMD | 0.00 | N/A | N/A | N/A | |
 Surmodics, Inc. NASDAQ:SRDX | 44.59M | 6.7% | 15.6% | 20.8% | |
 NeuroPace, Inc. NASDAQ:NPCE | 571.41M | 2.9% | 2.8% | N/A | |
 Treace Medical Concepts, Inc. NASDAQ:TMCI | 0.00 | N/A | N/A | N/A | |
 Owens & Minor, Inc. NYSE:OMI | 454.15M | 1.5% | 0.6% | 7.5% | |
 The Oncology Institute, Inc. NASDAQ:TOI | 256.71M | 7.9% | 8.9% | N/A |
Semler Scientific, Inc. Fair Value Envelope
Related Guides
Continue your SMLR research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.